Serum EPO and VEGF levels in patients with sleep-disordered breathing and acute myocardial infarction

[1] Yeo EJ(2008)Contribution of HIF-1alpha or HIF-2alpha to erythropoietin expression: in vivo evidence based on chromatin immunoprecipitation Ann Hematol 87 11-17

[2] Cho YS(2012)Prolonged therapy with erythropoietin is safe and prevents deterioration of left ventricular systolic function in a porcine model of myocardial infarction J Card Fail 16 579-589

[3] Kim MS(2003)Recombinant human erythropoietin protects the myocardium from ischemia–reperfusion injury and promotes beneficial remodeling Proc Natl Acad Sci U S A 100 4802-4806

[4] Park JW(2003)A novel protective effect of erythropoietin in the infarcted heart J Clin Invest 112 999-1007

[5] Angeli FS(2008)Sleep apnea and cardiovascular disease: an American Heart Association/American College Of Cardiology Foundation Scientific Statement from the American Heart Association Council for High Blood Pressure Research Professional Education Committee, Council on Clinical Cardiology, Stroke Council, and Council On Cardiovascular Nursing. In collaboration with the National Heart, Lung, and Blood Institute National Center on Sleep Disorders Research (National Institutes of Health) Circulatio

[6] Amabile N(2010)Obstructive sleep apnea as a risk factor for coronary events or cardiovascular death Sleep Breath 14 131-136

[7] Burjonroppa S(2009)Obstructive sleep apnea in patients admitted for acute myocardial infarction. Prevalence, predictors, and effect on microvascular perfusion Chest 135 1488-1495

[8] Shapiro M(1996)Sleep-disordered breathing in men with coronary artery disease Chest 109 659-663

[9] Bartlett L(2006)Ischemic preconditioning as a possible explanation for the age decline relative mortality in sleep apnea Med Hypotheses 66 1069-1073

[10] Zhang Y(2007)Signs and symptoms of sleep apnea and acute stroke severity: is sleep apnea neuroprotective? J Stroke Cerebrovasc Dis 16 114-118

[1] Yeo EJ(2008)Contribution of HIF-1alpha or HIF-2alpha to erythropoietin expression: in vivo evidence based on chromatin immunoprecipitation Ann Hematol 87 11-17

[2] Cho YS(2012)Prolonged therapy with erythropoietin is safe and prevents deterioration of left ventricular systolic function in a porcine model of myocardial infarction J Card Fail 16 579-589

[3] Kim MS(2003)Recombinant human erythropoietin protects the myocardium from ischemia–reperfusion injury and promotes beneficial remodeling Proc Natl Acad Sci U S A 100 4802-4806

[4] Park JW(2003)A novel protective effect of erythropoietin in the infarcted heart J Clin Invest 112 999-1007

[5] Angeli FS(2008)Sleep apnea and cardiovascular disease: an American Heart Association/American College Of Cardiology Foundation Scientific Statement from the American Heart Association Council for High Blood Pressure Research Professional Education Committee, Council on Clinical Cardiology, Stroke Council, and Council On Cardiovascular Nursing. In collaboration with the National Heart, Lung, and Blood Institute National Center on Sleep Disorders Research (National Institutes of Health) Circulatio

[6] Amabile N(2010)Obstructive sleep apnea as a risk factor for coronary events or cardiovascular death Sleep Breath 14 131-136

[7] Burjonroppa S(2009)Obstructive sleep apnea in patients admitted for acute myocardial infarction. Prevalence, predictors, and effect on microvascular perfusion Chest 135 1488-1495

[8] Shapiro M(1996)Sleep-disordered breathing in men with coronary artery disease Chest 109 659-663

[9] Bartlett L(2006)Ischemic preconditioning as a possible explanation for the age decline relative mortality in sleep apnea Med Hypotheses 66 1069-1073

[10] Zhang Y(2007)Signs and symptoms of sleep apnea and acute stroke severity: is sleep apnea neuroprotective? J Stroke Cerebrovasc Dis 16 114-118